Addus HomeCare's quarterly revenue has risen to $387.7M in 2026Q3, but year-over-year growth has slowed to 7.0% from 25.0% a year earlier, suggesting acquisition-driven expansion is maturing into a slower organic cadence.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 3, 2026 | $1.83+2.2% vs $1.79 | $388M-0.3% vs $389M |
Q3 2026 Aug 3, 2026 | $1.73+1.8% vs $1.70 | $377M+0.3% vs $376M |
Q2 2026 May 4, 2026 | $1.62+6.6% vs $1.52 | $364M-0.8% vs $366M |
Q1 2026 Feb 23, 2026 | $1.77+3.5% vs $1.71 | $372M-0.2% vs $373M |
Addus HomeCare Corporation (NASDAQ: ADUS - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twelve ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have issued a buy rating on
Does Addus HomeCare (ADUS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Addus HomeCare (ADUS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Benchmark ADUS against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Addus HomeCare Corporation (ADUS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $124.31 | $2.32B | 20.79 | 23.21% | 7.39% | 9.81% | — | |
| $24.28 | $1.67B | 16.06 | 7.08% | 5.58% | 20.22% | — | |
| $181.08 | $10.55B | 26.91 | 18.72% | 7.03% | 16.61% | 0.14% | |
| $23.20 | $3.03B | -33.73 | 6.24% | -2.63% | -2.59% | — | |
| $7.34 | $1.52B | 52.92 | 46.06% | 0.59% | 12.46% | — | |
| $36.36 | $1.26B | 36.88 | 36.31% | 3.05% | 9.04% | — |
Addus HomeCare Corporation (ADUS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Addus HomeCare Corporation (ADUS) SEC filings — annual & quarterly reports (10-K, 10-Q)
Nov 3, 2026·SEC
Aug 3, 2026·SEC
Jun 10, 2026·SEC
Get notified when ADUS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Addus HomeCare Corporation (ADUS) stock FAQ — growth, dividends, profitability & financials explained
Addus HomeCare Corporation (ADUS) reported $1.50B in revenue over the trailing twelve months. Revenue was $1.42B in fiscal year 2025. That is 631% more than the $194.6M of fiscal year 2007.
Addus HomeCare Corporation (ADUS) grew revenue by 11.5% over the trailing twelve months, compared with the twelve months before.
Yes. Addus HomeCare Corporation (ADUS) earned $111.1M in net income over the trailing twelve months (a 7.4% net margin).
Addus HomeCare Corporation (ADUS) had a return on equity (ROE) of 9.8% over the trailing twelve months. That is below the market's typical 10-15%.
Addus HomeCare Corporation (ADUS) generated $142.5M in free cash flow over the trailing twelve months.
